122 related articles for article (PubMed ID: 9453027)
1. Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A.
Heinen F; Wissel J; Philipsen A; Mall V; Leititis JU; Schenkel A; Stücker R; Korinthenberg R
Neuropediatrics; 1997 Dec; 28(6):307-13. PubMed ID: 9453027
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
3. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis].
Aguilar-Rebolledo F; Hernández-Sánchez J; Rayo-Mares D; Soriano-Fonseca F; García-Muñoz L; Ruiz-Ponce J; Garrido-Ramírez E
Gac Med Mex; 2001; 137(5):403-11. PubMed ID: 11692809
[TBL] [Abstract][Full Text] [Related]
4. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin as a treatment for infantile cerebral palsy].
Pascual-Pascual SI; Sánchez de Muniain P; Roche MC; Pascual-Castroviejo I
Rev Neurol; 1997 Sep; 25(145):1369-75. PubMed ID: 9377292
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
9. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
Gibson N; Graham HK; Love S
Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
[TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
12. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
Suputtitada A; Suwanwela NC
Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
Voller B; Földy D; Hefter H; Auff E; Schnider P
Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin Type A. Indications and results].
Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
[TBL] [Abstract][Full Text] [Related]
19. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
[TBL] [Abstract][Full Text] [Related]
20. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.
Gilio F; Currà A; Lorenzano C; Modugno N; Manfredi M; Berardelli A
Ann Neurol; 2000 Jul; 48(1):20-6. PubMed ID: 10894212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
